Ziad Ali, MD, PhD
Ziad Ali, MD, is the Victoria and Esther Aboodi Cardiology Researcher, Louis V. Gerstner Jr. Scholar, Assistant Professor of Medicine at Columbia University Medical Center (CUMC) where he serves as the Director of Intravascular Imaging and Physiology and Director of the Cardio-renal program. He is also the Director of the Angiographic Core Laboratory at Cardiovascular Research Foundation. His clinical research interests focus on the use of intravascular imaging and physiology technologies such as optical coherence tomography, intravascular ultrasound and flow wire assessment to optimize coronary interventions. Dr. Ali is the Global PI of the International Multicenter Randomized Controlled Trials ILUMIEN IV, a comparison of optical coherence tomography to angiography to guide PCI and improve clinical outcomes. Dr. Ali was instrumental in the development and validation of the Resting-Full Cycle Ratio (RFR) to assess coronary artery stenosis severity. Dr. Ali pioneered techniques to perform diagnostic angiography with ultra-low contrast volumes and perform interventions without contrast administration, protecting patients with advanced kidney disease from the need for dialysis.
Allen Jeremias, MD, MSc
Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital in Roslyn, New York. He is also a member of the Cardiovascular Research Foundation in New York City where he currently serves as the Director of the Physiology Core Laboratory. He completed his medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, as well as Beth Israel Deaconess Medical Center, Harvard Medical School. Dr. Jeremias has numerous publications in the area of coronary physiology and intravascular imaging.
Martin B. Leon, MD
Martin B. Leon, MD, is a Mallah Family Professor of Cardiology at the Columbia University Medical Center College of Physicians and Surgeons and Director of the Center for Interventional Vascular Therapy (CIVT) at New York-Presbyterian Hospital/Columbia University Medical Center. Previously, Dr. Leon was also the Director of the Cardiac Catheterization Laboratories at New York-Presbyterian Hospital/Columbia University Medical Center and currently he serves on the Executive Board of the New York-Presbyterian/Columbia Heart Valve Center. Dr. Leon was the Founder of Transcatheter Cardiovascular Therapeutics (TCT) symposium and Chairman Emeritus of the Cardiovascular Research Foundation (CRF) in New York City and is currently CRF’s Co-Director, Medical Research and Education Division. TCT is the largest dedicated interventional cardiology meeting in the world and CRF is the largest independent not-for-profit cardiovascular research center in the world.
Gary S. Mintz, MD
Gary S. Mintz, MD, is a Senior Medical Advisor of the Cardiovascular Research Foundation and Co-Director of Transcatheter Cardiovascular Therapeutics (TCT). He is the author of 1,000 peer reviewed articles, 60 book chapters, 4 books, and 850 abstracts concerning various aspects of clinical cardiology, cardiac ultrasound, hemodynamics, cardiac radiology and coronary arteriography, interventional cardiology, and (especially) intravascular imaging and physiology. In 2005, Dr. Mintz published the single-authored textbook Intracoronary Ultrasound that has been translated into Chinese. Mintz received the Master of the Masters Career Achievement Award at the TCTAP-Cardiovascular Summit 2014 in Seoul, Korea, the Chien Foundation Outstanding Lectureship & Lifetime Achievement Award, also presented at TCTAP-Cardiovascular Summit 2014 in Seoul, Korea; the Outstanding Achievement Award at CBS 2017, Nanjing, China; the Career Achievement Award at NFIC 2018 in Krakow Poland.
Jeffrey W. Moses, MD
Jeffrey W. Moses, MD, Professor of Medicine at Columbia University College of Physicians and Surgeons. An internationally recognized interventional cardiologist, Dr. Moses has performed more than 20,000 interventional procedures, authored over 600 publications, and served as lead investigator for numerous national and international clinical studies that have demonstrated the effectiveness and safety of coronary stent placement. In 2002, Dr. Moses was the lead investigator on a large clinical trial, the first in the U.S. that demonstrated the enormous benefit that led to FDA approval of the first drug-coated stent now used in the vast majority of procedures. Most recently in on the Executive Committee of the PARTNER trial; they brought the first transcatheter aortic valve to clinical use in the US. He currently serves as Director of Interventional Cardiovascular Therapeutics at CUMC and as Director of Advanced Cardiac Interventions at St. Francis Heart Center in Roslyn, New York.
Richard A. Shlofmitz, MD, FACC
Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The Heart Center®, in Roslyn, New York. A pioneer in interventional cardiology, Dr. Shlofmitz has worked to advance the field, with a focus on optimizing outcomes with the development of Precision PCI. He is a founding co-director of the annual Intravascular Imaging and Coronary Physiology Workshop. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and OCT world-wide. His clinical research interests focus on optimizing coronary interventions and he serves on multiple scientific advisory boards and clinical trial steering committees to further this mission. Dr. Shlofmitz has been one of the largest enrollers for multiple clinical trials, including TWILIGHT, ILUMIEN III, and Onyx, with more than 75 publications in peer-reviewed journals and was first to perform coronary intravascular lithotripsy (IVL) in North America as part of the DISRUPT CAD III trial. He is the largest enroller of the ILUMIEN IV trial.
Andrew Berke, MD, has been an interventional cardiologist at St. Francis Hospital for 30 years. He received his medical degree at Brown University. His postgraduate medical, cardiology, and interventional cardiology training were all at New York Presbyterian-Columbia, where he was also a full-time faculty member before entering private practice. He has been at the forefront of advances in interventional cardiology. His research interests and publications have spanned the gamut from TIMI to TAVI. Dr. Berke is looking forward to participating in future studies of intravascular imaging, integration of non-invasive modalities into the catheterization laboratory, and furthering catheter-based treatments for structural heart disease. He is a Fellow of the American College of Physicians, a Fellow of the American College of Cardiology, and a Fellow of the Society of Coronary Angiography and Interventions.
Hiram Bezerra, MD, PhD, is Director, Cardiovascular Imaging Core Laboratory as well as Director, Director, Advanced Coronary and MCS at University Hospital Cleveland Medical Center. He is also an Associate Professor, Medicine at Case Western Reserve University School of Medicine. Previously, he served at Massachusetts General Hospital with extensive expertise in Cardiac Imaging, Interventional Cardiology, Optical Coherence Tomography and Computed Tomography.
Emmanouil S. Brilakis, MD, PhD, FACC, FAHA, FESC, FSCAI, is Director of the Center for Complex Coronary Interventions at the Minneapolis Heart Institute. Dr. Brilakis leads a large clinical trial group investigating treatment of chronic total occlusions, prevention and treatment of saphenous vein graft disease and complications, intracoronary imaging, radiation safety in the catheterization laboratory, and development of novel technologies. Dr. Brilakis has authored or co-authored over 500 manuscripts and has written the Manual of CTO Interventions, now in its 2nd edition. He directs the Manual of CTO interventions and Manual of non-CTO interventions youtube series, is a Trustee of the Society of Cardiovascular Angiography and Interventions and is on the board of the Cardiovascular Innovations Foundation. He is an associate editor for Circulation and an editorial board member and reviewer for several journals and grant agencies.
Jane Cao, MD, MPH, FACC, is St. Francis Hospital’s Director of Research and Cardiac Imaging. She is a nationally renowned cardiac imaging specialist and researcher. Dr. Cao received her degree from the Medical College of Fudan University in Shanghai, and completed her Residency in Internal Medicine and Fellowship in Cardiology at the University of Vermont. She earned a Master’s Degree in Biology at Smith College in Massachusetts, and an MPH at the Harvard School of Public Health. Prior to coming to St. Francis, Dr. Cao was a Senior Research Fellow at the National Institutes of Health. She has lectured extensively in both the U.S. and China on cardiac CT and MRI.
William Chung, MD, is a board certified cardiologist and interventional cardiologist. He earned his medical degree from the Albert Einstein College of Medicine, with subsequent fellowships at Boston University Medical Center and Stony Brook University Hospital. Dr. Chung performs complex coronary interventions, endovascular procedures, and structural heart interventions at St. Francis Hospital in Roslyn, New York.
Justin Davies, MD, is a consultant interventional cardiologist at Hammersmith Hospital, Imperial College NHS Trust, London. After training at Imperial College, he won a prestigious BHF research fellowship to study arterial haemodynamics. Since then he has continued to work on the development of mathematical algorithms to aid understanding of large artery physiology and to develop new tools to assess arterial disease. The holder of several patents, he has published widely in the field of hypertension, coronary and large artery physiology and is the winner of many national and international awards. He has several international collaborations, and is the developer of iFR and the co-principal investigator of the ADVISE studies, the DEFINE-FLAIR, ORBITA and DEFINE-PCI studies. Dr. Davies also has an interest in renal denervation, and has lead the first-in-man studies to evaluate the safety of this technique to patients with chronic systolic heart failure (REACH studies).
William Fearon, MD, graduated from Dartmouth College and received his medical degree from Columbia University College of Physicians and Surgeons, where he was elected into the Alpha Omega Alpha Medical Honor Society. He completed an Internal Medicine residency at Stanford University Medical Center serving an extra year as a Medical Chief Resident. He completed a General Cardiology and Interventional Cardiology fellowship at Stanford, spending his third year as the Chief Cardiology Fellow. He is currently a Professor of Medicine (Cardiology) and Director of Interventional Cardiology at Stanford University Medical Center. Dr. Fearon is board certified in cardiovascular medicine and interventional cardiology, and he is a fellow of the American College of Cardiology, the American Heart Association, and the Society of Cardiovascular Angiography and Interventions. He has been elected to the American Society for Clinical Investigation.
Hector M. Garcia-Garcia, MD, PhD, is now serving as an attending cardiologist for MedStar Heart & Vascular Institute and director of the Coronary Invasive Imaging Core Lab. Prior to joining the MHVI medical staff, Dr. Garcia-Garcia served as Director of the Core Lab of Invasive Imaging at Cardialysis—a leading cardiology clinical research organization—and as researcher at the Erasmus Medical Center in Rotterdam, The Netherlands and Inselspital in Bern, Switzerland. He received both a Master’s and Doctorate degree from the Erasmus University of Rotterdam. An accomplished researcher, Dr. Garcia-Garcia has widely published in many international medical journals (more than 530 publications – H-index of 61), authored book chapters in most renowned cardiovascular textbooks and has presented at cardiology conferences world-wide. He is an expert in innovative cardiovascular technology. He has mentored seven PhD students and published their thesis.
One of the nation’s preeminent cardiologists, Cindy Grines, MD, is a renowned researcher who pioneered primary percutaneous coronary intervention (PCI) for heart attacks. She has a long history of research, publications and clinical trial design with more than 400 publications, numerous book chapters and review chapters. Dr. Grines serves on the editorial boards of several major journals, nationally and internationally, and she has co-edited several medical handbooks. She is editor-in-chief of the Journal of Interventional Cardiology.
Jonathan Hill, MD, is a graduate of Cambridge and Edinburgh Universities, qualifying in 1992. He trained in cardiology at The London Chest and St. Bartholomew’s Hospitals. In 1999 he was awarded the first National Heart Lung and Blood Institute Bench to Bedside award and trained in basic science and interventional research within the Cardiovascular Branch of the National Institutes of Health in Bethesda, Maryland. He undertook a research program relating to stem and progenitor cells in cardiovascular disease with a particular interest in vascular repair. Dr. Hill completed his interventional cardiology training at the London Chest Hospital. In 2005, he was appointed as Clinical Senior Lecturer and Consultant Cardiologist at King’s College London. Dr. Hill is now the Director of the Cardiac Catheterization Laboratories at King’s College Hospital. His current practice is focused on complex interventional procedures especially chronic total occlusion and percutaneous left ventricular support. At King’s College he developed an active clinical programme using optical coherence tomography and is a strong advocate for a universal intravascular imaging approach to guide percutaneous intervention.
Dimitrios Karmpaliotis, MD, PhD is a member of the Center for Interventional Vascular Therapy at Columbia University Medical Center. Dr. Karmpaliotis specializes in advanced, complex coronary intervention. He brings a wealth of experience in percutaneous coronary interventions and will direct the new Chronic Total Occlusions, Complex and High Risk Angioplasty Program at CIVT. Dr. Karmpaliotis graduated from the University of Athens School of Health Sciences in 1996 and trained at the prestigious Beth Israel Deaconess Medical Center at Harvard Medical School. Before coming to Columbia University, Dr. Karmpaliotis was instrumental in building a world-class interventional cardiology program at Piedmont Heart Center in Atlanta, Georgia. Dr. Karmpaliotis has served as principal investigator on more than 50 clinical trials, with special interest in the development of techniques for treating chronic total occlusions in coronary arteries. As part of the CIVT faculty, Dr. Karmpaliotis will assist in the development of master-technician training programs, support the complex coronary fellowship program and contribute to the annual Transcatheter Cardiovascular Therapeutic Conference.
Ajay J. Kirtane, MD, SM, is Associate Professor of Medicine at Columbia University Medical Center (CUMC) and Director of the Cardiac Catheterization Laboratories at New York Presbyterian (NYP) Hospital / CUMC. Dr. Kirtane is a graduate of Princeton University and Columbia University College of Physicians and Surgeons, and completed his residency/chief residency in Internal Medicine at the University of California – San Francisco. He completed fellowships in Cardiovascular Disease and Coronary and Peripheral Vascular Intervention at Beth Israel Deaconess Medical Center / Harvard Medical School and has a Masters of Science in Clinical Epidemiology from the Harvard School of Public Health.
Michael S. Lee, MD, FACC, FSCAI, is an interventional cardiologist and Associate Professor of Medicine at the UCLA Medical Center. Dr. Lee has published over 110 peer-reviewed research articles, over 70 of which as first author. Dr. Lee has first-authored original, peer-reviewed research articles in the Journal of the American College of Cardiology, Journal of the American College of Cardiology: Cardiovascular Interventions, Annals of Thoracic Surgery, American Journal of Cardiology, EuroIntervention, Journal of Endovascular Therapy, and International Journal of Cardiology. He was the first author for the State of the Art articles in JACC Interventions for Saphenous Vein Graft Intervention and PCI for patients with acute myocardial infarction secondary to unprotected left main disease. He is one of the world’s authorities in orbital atherectomy and the treatment of cardiac allograft vasculopathy.
Paul J. Lee, MD, earned his medical degree at SUNY Buffalo in 1994. He completed his residency at Montefiore Medical Center continuing at North Shore-Long Island Jewish, then completed his Interventional Cardiology Fellowship in 2002. He joined South Bay Cardiovascular in Long Island in 2002, performing cardiac interventions at Good Samaritan and Southside Hospitals. In 2009, South Bay Cardiovascular affiliated with St. Francis Hospital, becoming one of the largest and most respected cardiovascular practices in the region. Dr. Lee specializes in treatment of complex coronary artery disease and peripheral vascular disease and TAVR procedures.
Andrew E. Lituchy, MD, FACC, is a full-time faculty clinical interventional cardiologist at St. Francis Hospital in Roslyn, New York since 1996 where he has performed over 5,000 percutaneous coronary interventions. He completed his general and interventional cardiology training at New York Hospital in 1995. His interests include intravascular imaging and physiology.
Akiko Maehara, MD, is the Director of the Intravascular Imaging Core Laboratory at the CRF Clinical Trials Center. She is also an Assistant Professor of Medicine at Columbia University College of Physicians and Surgeons in New York. She is a leading authority in the field of intravascular imaging and physiology. Dr. Maehara received her medical degree from Yamaguchi University School of Medicine in Yamaguchi, Japan. She completed her cardiovascular fellowship at the Cardiovascular Center in Toranomon Hospital in Tokyo. Dr. Maehara finished a research fellowship at Stanford University and at the Washington Hospital Center in Washington, DC.
Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI; Professor of Medicine, Cardiology and Professor of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai is internationally renowned in the field of interventional cardiovascular disease. As Director of Interventional Cardiovascular Research and Clinical Trials at Mount Sinai, she has developed a globally-respected data and clinical coordination center. A prolific researcher and author, she has served as principal investigator for numerous large global studies, developed risk scores for bleeding and acute kidney injury, and authored >800 peer-reviewed articles. She received numerous prestigious awards, the 2017 Bernadine Healy Leadership in Women’s CV Disease Award, and in May 2018, Wenger Award for Excellence in Medical Leadership. She co-founded the Academic Research Consortium (ARC) and SCAI-WIN. A founding physician of the Cardiovascular Research Foundation, and currently Chief Scientific Officer.
Thomas Pappas, MD, is Director of St. Francis Hospital’s Cardiac Catheterization Laboratory. In this capacity, he has participated in numerous clinical trials evaluating novel coronary interventional devices. He is a graduate of Cornell University Medical College, practicing both interventional as well as consultative cardiology for the past 25 years at St. Francis Hospital. Dr. Pappas has consistently been recognized by Newsday and Castle Connolly as one of the top physicians on Long Island and has been selected as one of New York magazine’s Best Doctors.
Manesh Patel, MD, is the Chief of the Division of Cardiology and the Division of Clinical Pharmacology at the Duke University Medical Center. His clinical interests include diagnostic and interventional coronary angiography, peripheral angiography and endovascular intervention. His is involved in several clinical trials involving patients with cardiovascular disease and in cardiac imaging. He is also the Chair of the American College of Cardiology Task Force for Appropriate Use Criteria for Cardiovascular Procedures and is Chair of the American Heart Association Diagnostic. Patel’s interest in cardiac imaging, quality of care, cardiac devices is also evident in his research. His integration of these efforts into his roles at Duke was recognized in 2010 when he received the prestigious Duke Cardiology Fellowship Mentor Award. In 2011, Dr. Patel was named the endowed John Bush Simpson Assistant Professor of Cardiology. In 2013, Dr. Patel received the Robert M. Califf Faculty clinical research Award.
George Petrossian, MD, is Director of Interventional Cardiovascular Procedures at St. Francis Hospital, as well as Co-Director of St. Francis Hospital’s Heart Valve Center. He is a board certified cardiologist and interventional cardiologist who has been a Principal Investigator for a number of nationwide studies that have transformed the treatment of heart disease. His pioneering research helped win FDA approval of CoreValve, a minimally invasive device that offers new hope for patients with aortic stenosis too frail to undergo open heart surgery.
Francesco Prati, MD, is Director of a Research center with dedicated core lab since 1998 matured great expertise in the central core-lab lecture of ECG, ECHO, QCA, IVUS, NIRS and angiographic microcirculatory index (TIMI, TFC, MPG) and in the development, validation and clinical application of novel intravascular imaging modalities, such as Optical Coherence Tomography and IVUS-derived techniques, to study plaque vulnerability.
Matthew J. Price, MD, is the Director of the Cardiac Catheterization Laboratory in the Division of Cardiovascular Diseases at Scripps Clinic. He specializes in both coronary and percutaneous approaches to structural and congenital heart disease that include LAA closure, transcatheter mitral valve repair, ASD/PFO closure. and more. Dr. Price is Editor-In-Chief of Interventional Cardiology Clinics, and served as the editor of a major textbook on coronary stenting. He also serves as a section editor for the Journal of the American College of Cardiology. Dr. Price has authored, or co-authored, more than 130 publications in peer-reviewed academic journals, and has been twice awarded the Scripps Clinic Department of Medicine Chairman’s Award for Research in Medicine. He has led or served in the leadership of several clinical trials and national registries of antiplatelet therapy, drug-eluting stents, left atrial appendage closure, intravascular imaging, and coronary physiology.
Sunil V. Rao MD, FACC, FSCAI, is Professor of Medicine at Duke University Medical Center, and the Section Chief of Cardiology at the Durham VA Medical Center. His main research interests are pharmacological and interventional therapies for acute coronary syndromes, as well as bleeding and blood transfusion complications among patients with ischemic heart disease. At the national level, Dr. Rao serves as the Editor-in-Chief for Circulation Cardiovascular Interventions, the interventional journal of the American Heart Association’s flagship Circulation family of journals. He also serves on the program committees of the ACC Scientific Sessions, the Transcatheter Cardiovascular Therapeutics conference, and the SCAI Scientific Sessions. He was the chairman of the 2017 ACC-i2 Summit and is the chair of the SCAI 2019 Annual Scientific Session. In addition, he was the Editor-in-Chief of the ACC CathSAP 5 program and is currently the co-chair of the ACC Collaborative Management Pathway.
Newell Robinson, MD, is Chairman of Cardiothoracic and Vascular Surgery at St. Francis Hospital, as well as
Co-Director of the Heart Valve Center at St. Francis Hospital. He is a board certified cardiothoracic surgeon who has been recognized nationally for his expertise in minimally-invasive cardiac surgery. As Co-Principal Investigator of the CoreValve clinical study, his published findings, helped gain FDA approval of the device. Dr. Robinson has also been pivotal in bringing state-of-the-art technology to St. Francis Hospital, including a hybrid OR that allows interventional cardiologists and cardiothoracic surgeons to work side by side for the benefit of patients. Dr. Robinson is consistently cited on New York magazine’ Best Doctors list, in addition to being rated among the top physicians in the country by Castle Connolly.
Dr. Habib Samady trained in general cardiology, nuclear cardiology and interventional cardiology at Yale University. He joined Emory University in 2005. In 2009, he became Professor of Medicine and in 2011, Director of Interventional Cardiology at Emory University and Director of the Cardiac Catheterization Laboratory of Emory University Hospital. He has received several outstanding teaching awards. Dr. Samady has an actively funded clinical and translational research program to investigate:
Dr. Samady is Deputy Editor of JACC Cardiovascular Interventions, is on the editorial board of numerous cardiovascular journals, and is extensively published.
Bruce Samuels, MD, is an interventional cardiologist on staff at Cedars-Sinai Medical Center (CSMC) in Los Angeles, CA. Dr. Samuels completed his medical studies at Albert Einstein College of Medicine in New York before returning to Southern California to complete his residency and chief residency in Internal Medicine at Harbor-UCLA Medical Center. At CSMC, he trained in both general and interventional cardiology before joining the medical staff there. In addition to his clinical practice in coronary intervention, Dr. Samuels has actively participated in numerous interventional trials including IVUS guided therapy, functional measurement and microvascular disease. He is also working closely with the Women’s Heart Center based at CSMC, working as the lead interventionist of the active coronary reactivity research there. As co-chair of a 30-day readmissions task force, he has helped to shape policy for CSMC in its efforts to improve quality delivery of care. Dr. Samuels has frequently been invited as faculty to many scientific meetings and is a sought after speaker for numerous peer educational platforms.
Erick Schampaert, MD, is an Associate Professor and Head of the Division of Cardiology at the Université de Montréal, since 2006. He is also an interventional cardiologist at Hôpital du Sacré-Cœur de Montreal, since 1997. He served as the President of the Canadian Association of Interventional Cardiology from 2007-2011. His interests include LM PCI, Coronary physiology (FFR, iFR, CFR) and imaging (IVUS-OCT), STEMI. He participates in clinical trials, including a major role in the C-SIRIUS, E-SIRIUS, EXCEL, CCS CIHI PCI QI WG trials. Additionally, he is a local Principal Investigator for more than 75 trials. He currently serves as Director of Canadian Coronary Physiology and Invasive Imaging symposium (CPI) and as Co-Director of Tremblant Interventional Cardiology (TIC).
Arnold H. Seto, MD, is Chief of Cardiology at the Long Beach VA Medical Center in California, and Associate Clinical Professor and Director of Interventional Cardiology Research at the University of California, Irvine Medical Center. He has been an active participant in several research trials including DEFINE-FLAIR, DEFINE-PCI, and ACIST-FFR, as well as lead investigator of the FAUST and RAUST trials. His areas of interest include coronary physiology, vascular access, and intracoronary imaging.
Professor Sharp qualified from Edinburgh Medical School in 1998 and conducted his early training at the Royal Infirmary of Edinburgh, before moving to London for senior clinical training. He completed the Milan-Imperial College Interventional Cardiology Fellowship programme before being appointed Consultant Cardiologist at the Royal Devon and Exeter Hospital in 2011. He was appointed Honorary Associate Professor at the University of Exeter in 2018. He has been Principal Investigator in more than 30 ethically-approved research trials since 2012, and is on the steering committees of six major national and international multicenter trials, including trials of coronary physiology and intravascular ultrasound guidance to improve outcomes. He is course director of the London-based course: Advances in Coronary Imaging, a course focusing on the use of intravascular ultrasound in PCI. He is also course co-director of Co-Registration of Intracoronary Physiology and Imaging.
Evan Shlofmitz, DO, is an Interventional Cardiology fellow at MedStar Washington Hospital Center. He previously completed an Intravascular Imaging and Physiology fellowship at the Cardiovascular Research Foundation (CRF) and Columbia University Medical Center (CUMC) after his Cardiovascular Disease fellowship at Northwell Health. Dr. Shlofmitz’s research interests have centered on intravascular imaging and Precision PCI, with more than 40 publications in peer-reviewed journals.
Paul Teirstein, MD, is the Chief of Cardiology and Director of Interventional Cardiology for Scripps Clinic and Director of the Scripps Prebys Cardiovascular Institute for Scripps Health. With a primary focus on complex coronary interventions and new technology development, Dr. Teirstein has played an active role in the initial development and clinical investigation of coronary stent procedures, rotablator atherectomy, coronary angioscopy and the utilization of cardiopulmonary support. Dr. Teirstein pioneered the first effective treatment for restenosis (low dose radiation therapy) and was one of the early investigators of medicated and bioabsorbable stents. Recent areas of investigation include new technology for minimally invasive transcatheter aortic valve replacement (TAVR). Dr. Teirstein currently performs in excess of 800 stent procedures per year and maintains an active clinical research and teaching unit at Scripps Clinic where he strives to offer patients the most advanced cardiovascular care available worldwide.
Ron Waksman, MD, FACC, Associate Director, Division of Cardiology, MedStar Washington Hospital Center (MWHC) and Director of Cardiovascular Research and Advanced Education for the MedStar Heart and Vascular Institute at the MedStar Washington Hospital Center. With nearly 20 years of experience in leading edge medical technologies, Dr. Waksman is a world-renowned interventional cardiologist and is a highly sought after Principal Investigator for pre-clinical and clinical studies conducted in the United States and abroad. His current research interests include brachytherapy for restenosis prevention bioabsorbable/ biodegradable stents, HDL therapy, intracoronary imaging, valvular heart disease and catheter-based treatment of renal denervation.
Giora Weisz, MD, the Section-Head and director of the interventional cardiology program at Montefiore Medical Center in New York. He serves also as faculty of the Cardiovascular Research Foundation (CRF). Dr. Weisz graduated from the Hebrew University-Hadassah Medical School in Jerusalem, Israel. He completed his cardiology fellowship training at the Carmel Medical Center-Technion School of Medicine in Haifa, Israel, and underwent advanced training in interventional cardiology at Lenox Hill Hospital and the CRF in NYC. He has pioneered the use of novel robotic-enhanced coronary interventions, navigation and positioning technologies. Dr. Weisz has been the Principal Investigator for pivotal clinical studies leading to FDA approval of cutting-edge technologies for interventional cardiology device positioning and navigation and robotics, as well leading multicenter studies in interventional imaging and the combination of PCI with pharmacological anti-ischemic treatment. Dr. Weisz is an internationally recognized researcher that has published extensively in the most prestigious peer-review medical journals.